<DOC>
	<DOCNO>NCT02172326</DOCNO>
	<brief_summary>Study evaluate pharmacokinetics tiotropium follow 14 day administration ( 18µg per day ) elderly COPD patient .</brief_summary>
	<brief_title>Pharmacokinetic Study Elderly Patients With Chronic Obstructive Bronchitis ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>All patient require diagnosis COPD meet follow spirometric criterion : Relatively stable , moderate severe airway obstruction FEV1 ≤ 65 % predict normal FEV1/FVC ≤ 70 % Patients require normal renal clearance . Renal clearance evaluate determination creatinine clearance . To qualify trial , patient 's measure creatinine clearance require within 20 % calculated creatinine clearance , give follow equation : Males : Calculated Creatinine Clearance ( ml/min ) = [ 140 Age ( yr ) ] x weight ( kg ) / 72 x serum creatinine ( mg/dL ) Females : Calculated Creatinine Clearance ( ml/min ) = [ 140 Age ( yr ) ] x weight ( kg ) / 85 x serum creatinine ( mg/dL ) Both male female patient eligible . Twelve patient ≥ 70 year old twelve patient ≤ 50 year Patients require smoke history ten packyears , packyear define equivalent smoke one pack cigarettes per day year Patients must able perform specify procedure maintain record study period require protocol Patients require able inhale medication HandiHaler® Patients require sign Informed Consent Form prior participation trial , include necessary prior prestudy washout usual pulmonary medication Patients significant disease COPD exclude participation trial . A significant disease define disease opinion investigator may either put patient risk participation trial disease may influence result trial patient 's ability participate trial ; Patients clinically significant abnormal baseline haematology , blood chemistry urinalysis , abnormality define disease list exclusion criterion ; Patients alanine transaminase ( ALT/SGOT ) &gt; 80 IU/L aspartate transaminase ( AST/SGPT ) &gt; 80 IU/L , bilirubin &gt; 2.0 mg/dL creatinine &gt; 2.0 mg/dL exclude participation trial , regardless patient 's clinical condition . Repeat laboratory evaluation conduct patient ; Patients recent history ( i.e. , one year less ) myocardial infarction ( MI ) ; Patients recent history ( i.e. , three year less ) heart failure patient cardiac arrhythmia require drug therapy ; Patients regular use daytime oxygen therapy ; Patients know active tuberculosis ; Patients history cancer within last five year . However , patient treat basal cell carcinoma allow participate ; Patients history lifethreatening pulmonary obstruction , history cystic fibrosis bronchiectasis ; Patients undergone thoracotomy pulmonary resection . Patients history thoracotomy reason evaluate per exclusion criterion # 1 ; Patients develop upper respiratory tract infection six week prior Screening Visit ( Visit 1 ) baseline period ; Patients know hypersensitivity anticholinergic drug , lactose component inhalation capsule delivery system ; Patients know symptomatic prostatic hypertrophy bladder neck obstruction ; Patients know narrowangle glaucoma ; Patients treat cromolyn sodium nedocromil sodium ; Patients treat antihistamine ( H1 receptor antagonist ) ; Patients use oral corticosteroid medication unstable dos ( i.e . le six week stable dose ) dose excess equivalent 10 mg prednisone per day ( 20 mg every day ) ; Pregnant nursing woman woman childbearing potential use medically approve mean contraception ( i.e . oral contraceptive , intrauterine device , diaphragm Norplant® ) ; Patients history asthma , allergic rhinitis atopy patient total blood eosinophil count ≥ 600/mm3 . A repeat eosinophil count conduct patient ; Patients history and/or active alcohol drug abuse . Patients take investigational drug within one month six half life ( whichever great ) prior Screening Visit ( Visit 1 ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>